Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Aebischer

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Brain Research|November 19, 1993
Substance P containing polymer implants protect against striatal excitotoxicityP R Sanberg, D F Emerich, P Aebischer, et al.
Human Gene Therapy|January 26, 2000
Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's diseaseN Déglon, J L Tseng, J C Bensadoun, et al.
Experimental Neurology|January 12, 2000
Lentiviral gene transfer to the nonhuman primate brainJ H Kordower, J Bloch, S Y Ma, et al.
Gene Therapy|December 16, 2005
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primatesS Behrstock, A Ebert, J McHugh, et al.
Gene Therapy|April 22, 2003
Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retinaC Kostic, F Chiodini, P Salmon, et al.
Circulation|April 10, 2002
Cardiovascular aging is associated with vitamin E increaseBernd van der Loo, Ralf Labugger, Claude P Aebischer, et al.
The Journal of Comparative Neurology|April 29, 2009
Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNFD E Redmond, J D Elsworth, R H Roth, et al.
Journal of Biomedical Materials Research|June 1, 1995
Synthesis and characterization of fluoropolymeric substrata with immobilized minimal peptide sequences for cell adhesion studies. IT G Vargo, E J Bekos, Y S Kim, et al.
Nature Medicine|June 1, 1996
Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patientsP Aebischer, M Schluep, N Déglon, et al.
Human Gene Therapy|August 24, 2000
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTFA C Bachoud-Lévi, N Déglon, J P Nguyen, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Brain Research|November 19, 1993
Substance P containing polymer implants protect against striatal excitotoxicityP R Sanberg, D F Emerich, P Aebischer, et al.
Human Gene Therapy|January 26, 2000
Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's diseaseN Déglon, J L Tseng, J C Bensadoun, et al.
Experimental Neurology|January 12, 2000
Lentiviral gene transfer to the nonhuman primate brainJ H Kordower, J Bloch, S Y Ma, et al.
Gene Therapy|December 16, 2005
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primatesS Behrstock, A Ebert, J McHugh, et al.
Gene Therapy|April 22, 2003
Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retinaC Kostic, F Chiodini, P Salmon, et al.
Circulation|April 10, 2002
Cardiovascular aging is associated with vitamin E increaseBernd van der Loo, Ralf Labugger, Claude P Aebischer, et al.
The Journal of Comparative Neurology|April 29, 2009
Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNFD E Redmond, J D Elsworth, R H Roth, et al.
Journal of Biomedical Materials Research|June 1, 1995
Synthesis and characterization of fluoropolymeric substrata with immobilized minimal peptide sequences for cell adhesion studies. IT G Vargo, E J Bekos, Y S Kim, et al.
Nature Medicine|June 1, 1996
Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patientsP Aebischer, M Schluep, N Déglon, et al.
Human Gene Therapy|August 24, 2000
Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTFA C Bachoud-Lévi, N Déglon, J P Nguyen, et al.
Pageof 18